Well I think VGH's results were really in line with expectations.
refractive continues to disappoint, but the non-discretionary side is really the heart of the operation, and that seems to be tracking well.
I must admit I was surprised to here that organic growth in opthalmology may be limited going forward, hence they are exploring other specialities such as plastics. I'm not sure I can see too many similarities between plastics and opthalmology, so VGH will remain in the "tradeable" mental file for the next little while.
- Forums
- ASX - By Stock
- VGH
- results
results
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VGH (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online